BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15056811)

  • 1. Ethyl acrylate risk assessment with a hybrid computational fluid dynamics and physiologically based nasal dosimetry model.
    Sweeney LM; Andersen ME; Gargas ML
    Toxicol Sci; 2004 Jun; 79(2):394-403. PubMed ID: 15056811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways.
    Frederick CB; Bush ML; Lomax LG; Black KA; Finch L; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB; Ultman JS
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):211-31. PubMed ID: 9772217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry comparisons of ester vapors.
    Frederick CB; Lomax LG; Black KA; Finch L; Scribner HE; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB
    Toxicol Appl Pharmacol; 2002 Aug; 183(1):23-40. PubMed ID: 12217639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hybrid computational fluid dynamics and physiologically based pharmacokinetic model for comparison of predicted tissue concentrations of acrylic acid and other vapors in the rat and human nasal cavities following inhalation exposure.
    Frederick CB; Gentry PR; Bush ML; Lomax LG; Black KA; Finch L; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB; Ultman JS
    Inhal Toxicol; 2001 May; 13(5):359-76. PubMed ID: 11295868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: an example with acrylic acid.
    Andersen M; Sarangapani R; Gentry R; Clewell H; Covington T; Frederick CB
    Toxicol Sci; 2000 Oct; 57(2):312-25. PubMed ID: 11006361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a pharmacokinetic-driven computational fluid dynamics model to predict nasal extraction of hydrogen sulfide in rats and humans.
    Schroeter JD; Kimbell JS; Andersen ME; Dorman DC
    Toxicol Sci; 2006 Dec; 94(2):359-67. PubMed ID: 16984956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of tissue reaction kinetics in a computational fluid dynamics model for nasal extraction of inhaled hydrogen sulfide in rats.
    Schroeter JD; Kimbell JS; Bonner AM; Roberts KC; Andersen ME; Dorman DC
    Toxicol Sci; 2006 Mar; 90(1):198-207. PubMed ID: 16344266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically based modeling of vinyl acetate uptake, metabolism, and intracellular pH changes in the rat nasal cavity.
    Plowchalk DR; Andersen ME; Bogdanffy MS
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):386-400. PubMed ID: 9070362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computational fluid dynamics approach to assess interhuman variability in hydrogen sulfide nasal dosimetry.
    Schroeter JD; Garcia GJ; Kimbell JS
    Inhal Toxicol; 2010 Mar; 22(4):277-86. PubMed ID: 20064104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A real-time methodology to evaluate the nasal absorption of volatile compounds in anesthetized animals.
    Thrall KD; Woodstock AD; Soelberg JJ; Gargas ML; Kinzell JH; Corley RA
    Inhal Toxicol; 2009 May; 21(6):531-6. PubMed ID: 19519153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human.
    Gargas ML; Tyler TR; Sweeney LM; Corley RA; Weitz KK; Mast TJ; Paustenbach DJ; Hays SM
    Toxicol Appl Pharmacol; 2000 May; 165(1):63-73. PubMed ID: 10814554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PBPK model for evaluating the impact of aldehyde dehydrogenase polymorphisms on comparative rat and human nasal tissue acetaldehyde dosimetry.
    Teeguarden JG; Bogdanffy MS; Covington TR; Tan C; Jarabek AM
    Inhal Toxicol; 2008 Feb; 20(4):375-90. PubMed ID: 18302046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human.
    Gargas ML; Tyler TR; Sweeney LM; Corley RA; Weitz KK; Mast TJ; Paustenbach DJ; Hays SM
    Toxicol Appl Pharmacol; 2000 May; 165(1):53-62. PubMed ID: 10814553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endogenous formaldehyde in nasal tissues on inhaled formaldehyde dosimetry predictions in the rat, monkey, and human nasal passages.
    Schroeter JD; Campbell J; Kimbell JS; Conolly RB; Clewell HJ; Andersen ME
    Toxicol Sci; 2014 Apr; 138(2):412-24. PubMed ID: 24385418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of human physiologically based pharmacokinetic model for vinyl acetate against human nasal dosimetry data.
    Hinderliter PM; Thrall KD; Corley RA; Bloemen LJ; Bogdanffy MS
    Toxicol Sci; 2005 May; 85(1):460-7. PubMed ID: 15659566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiological toxicokinetic model for inhaled propylene oxide in rat and human with special emphasis on the nose.
    Csanády GA; Filser JG
    Toxicol Sci; 2007 Jan; 95(1):37-62. PubMed ID: 17062723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a physiologically based pharmacokinetic (PBPK) model for methyl iodide in rats, rabbits, and humans.
    Sweeney LM; Kirman CR; Gannon SA; Thrall KD; Gargas ML; Kinzell JH
    Inhal Toxicol; 2009 May; 21(6):552-82. PubMed ID: 19519155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset.
    Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
    Toxicol Sci; 2004 Nov; 82(1):279-96. PubMed ID: 15254341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.